Adjuvant portal-vein infusion of fluorouracil and heparin in colorectal cancer: a randomised trial. European Organisation for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group, the Gruppo Interdisciplinare Valutazione Interventi in Oncologia, and the Japanese Foundation for Cancer Research.

Autor: Rougier P (AUTHOR), Sahmoud T (AUTHOR), Nitti D (AUTHOR), Curran D (AUTHOR), Doci R (AUTHOR), De Waele B (AUTHOR), Nakajima T (AUTHOR), Rauschecker H (AUTHOR), Labianca R (AUTHOR), Pector J (AUTHOR), Marsoni S (AUTHOR), Apolone G (AUTHOR), Lasser P (AUTHOR), Couvreur ML (AUTHOR), Wils J (AUTHOR), Rougier, P¹ (AUTHOR), Sahmoud, T (AUTHOR), Nitti, D (AUTHOR), Curran, D (AUTHOR), Doci, R (AUTHOR)

Publikováno v: Lancet. 6/6/1998, Vol. 351 Issue 9117, p1677-1681. 5p.

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses

Autor: Baum M, Buzdar A, Cuzick J, Forbes J, Houghton J, Howell A, Sahmoud T, ATAC Trialists' Group, DE LAURENTIIS, MICHELINO, DE PLACIDO, SABINO, CARLOMAGNO, Chiara

BACKGROUND: The first analysis of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial (median follow-up, 33 months) demonstrated that in adjuvant endocrine therapy for postmenopausal patients with early-stage breast cancer, anastrozole was s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ea3ed16bff74f754a8c1fc56307768a
http://hdl.handle.net/11588/423019

Final results of a phase III clinical trial of adjuvant chemotherapy with the modified fluorouracil, doxorubicin, and mitomycin regimen in resectable gastric cancer

Autor: Lise, M, Nitti, Donato, Marchet, A, Sahmoud, T, Buyse, M, Duez, N, Fiorentino, M, GUIMARAES DOS SANTOS, J, Labianca, R, Rougier, P, Gignooux, M, Pedrazzoli, S.

Publikováno v: Journal of Clinical Oncology. 13:2757-2763

PURPOSE In a randomized clinical trial (European Organization for the Research and Treatment of Cancer [EORTC] no. 40813) on adjuvant chemotherapy in gastric cancer, results obtained after administration of the FAM2 regimen (fluorouracil [5-FU], doxo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b6e64e615ecfe7b366c4dba4e075467
https://doi.org/10.1200/jco.1995.13.11.2757

Everolimus treatment of subependymal giant cell astrocytomas (SEGA's) associated with tuberous sclerosis complex (TSC): the EXIST-I trial

Autor: Sparagana, S., Belousova, Elena, Jozwiak, Sergiusz, Korf, Bruce, Frost, M., Kuperman, Rachel, Kohrman, M., Witt, Olaf, Wu, J., Flamini, Robert, Jansen, Anna, Curtalolo, P., Thiele, Elizabeth, Whittemore, V., De Vries, Petrus, Ford, James, Shah, Gaurav, Cauwel, H., Edrich, Pascal, Sahmoud, T., Franz, David

TSC is a genetic disorder caused by mutations in either the TSC1 (encoding hamartin) or TSC2 (encoding tuberin) genes. Hamartin and tuberin normally form a dimer that inhibits mammalian target of rapamycin (mTOR); mutation of either TSC1 or TSC2 resu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3848::1bb250433fe7e010063679bea6c4eec7
https://biblio.vub.ac.be/vubir/everolimus-treatment-of-subependymal-giant-cell-astrocytomas-segas-associated-with-tuberous-sclerosis-complex-tsc-the-existi-trial(bfd369b0-0eba-4256-9e43-d4126b584f31).html

The first results of the ATAC trial (Arimidex, Tamoxifen Alone or in Combination): an adjuvant trial in postmenopausal women with early breast cancer

Autor: Baum, M, Buzdar, AU, Cuzick, J, Forbes, J, Houghton, J, Klijn, Jan, Sahmoud, T

Publikováno v: Lancet (UK), 359, 2131-2139. Elsevier Ltd.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::989c30af1e9bbd4659151b497e32d0a4
https://pure.eur.nl/en/publications/8383906f-7038-4de0-9db0-7838b33aa47f